US Patent Issued to Cedars-Sinai Medical Center on Sept. 29 for "Complex microfluidic models for ALS including NF biomarkers for ALS research and drug development" (California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,748,102, issued on Sept. 29, was assigned to Cedars-Sinai Medical Center (Los Angeles).

"Complex microfluidic models for ALS including NF biomarkers for ALS research and drug development" was invented by Samuel Sances (Santa Monica, Calif.) and Clive Svendsen (Pacific Palisades, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are the effects of continuous media perfusion on SC-Chips and the observed activation of pronounced neural tissue growth and vascular recruitment into the neural tissue channel. ALS patient chip overexpression of known neurodegenerative disease biomarkers neurogranin and neurofilament family members are also...